CLRB
Cellectar Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$11.96M
P/E Ratio
—
EPS
$-8.35
Beta
0.40
52W High
$20.59
52W Low
$2.43
50-Day MA
$3.10
200-Day MA
$4.13
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Cellectar Biosciences Inc
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development and commercialization of drugs for the treatment of cancer. The company is headquartered in Florham Park, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-22.77M |
| Operating Margin | 0.00% |
| Return on Equity | -170.30% |
| Return on Assets | -71.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.89 |
| Price-to-Book | 1.35 |
| Price-to-Sales (TTM) | 348.47 |
| EV/Revenue | 314.45 |
| EV/EBITDA | -3.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.24M |
| Float | $4.08M |
| % Insiders | 3.91% |
| % Institutions | 8.70% |
Historical Volatility
HV 10-Day
56.78%
HV 20-Day
57.23%
HV 30-Day
77.50%
HV 60-Day
85.61%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($33.33 target)
2
Buy1
HoldData last updated: 4/10/2026